Profile
BioSyent is a profitable growth-oriented specialty pharmaceutical company focused on in-licensing or acquiring innovative pharmaceutical products that have been successfully developed, are proven safe and effective, and have track records of improving the lives of patients. BioSyent supports the healthcare professionals that treat these patients by marketing its products through its community, hospital, and international business units. BioSyent continues to search for products to in-license or acquire that match the following criteria:
- Are unique and occupy a niche in the market;
- Provide novel technological or therapeutic advantages to patients and healthcare professionals;
- Are backed by strong partners who hold defendable intellectual property rights.
Website
Contact
-
Ramesh Moothan, Director of International BusinessEmail: rmoothan@biosyent.com
-
-
-
-
-
Event details
Date: November 6 - 8, 2023
Event contact
Patrick Barry
Area Director
Europe: Automotive and Life Sciences
Tel: +1 416-407-7645
Email: patrick.barry@ontario.ca
Participants
21 in total
-
Basetwo is a low-code platform that enables scientists and engineers to easily build digital twins of their lab, pilot… -
BioSyent is a profitable growth-oriented specialty pharmaceutical company focused on in-licensing or acquiring…
-
Bright Angel Therapeutics (BAT) is a pre-clinical stage biotechnology company focused on the development… -
Canurta is revolutionizing healthcare by developing innovative botanical therapeutics using rare cannflavins for… -
Mississauga's life sciences sector is a thriving hub of innovation and growth. With a highly skilled workforce and… -
Custom Biologics provides regulatory compliant biological testing and assay services for all phases of biotherapeutic… -
Cybin is a leading ethical biopharmaceutical company, working with a network of world-class partners and… -
Edesa Biotech, Inc. (Nasdaq: EDSA) is a clinical-stage biopharmaceutical company developing innovative… -
Medexus Pharmaceuticals Inc. is a leading innovative and rare disease pharmaceutical company that has core capabilities… -
Nanovista is developing novel, multi-modality imaging agents for oncology. Nanovista is enabling surgical oncologists… -
Omnium Global is a Toronto-based scientific management consulting firm that has been delivering solutions to clients… -
Orion Biotechnology is a clinical stage company founded in 2017, with established R&D operations in Geneva,… -
Pluristyx, powered by panCELLa, is an advanced therapy tools and services company whose primary mission is to help… -
PolyAnalytik Inc. (PAI) was founded in 2007 and incorporated in May 2008 with its headquarters… -
ProteinQure is the best computational platform for peptide drug discovery. ProteinQure partners with pharma to deliver… -
Q&C Services wrote the book on regulatory compliance. Over 150,000 copies of its authoritative, pocket sized Blue… -
QurCan Therapeutics is a biotech company that utilizes next-generation tissue-selective, blood-brain barrier-… -
Spiderwort is a biotechnology company with a transformative platform of cellulose-based biomaterials that will serve as… -
Sterimax Inc is the largest privately owned provider of sterile injectables in Canada. Sterimax is a fast growing… -
TREVENTIS™ Corporation is dedicated to treating and preventing protein misfolding diseases. its innovative… -
Virica is a viral vector enhancer company. Virica pioneered a new enhancer category called Viral Sensitizers (…